SinuSonic for Nasal Congestion
Trial Summary
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications. It's best to consult with the trial coordinators for guidance.
What data supports the idea that SinuSonic for Nasal Congestion is an effective treatment?
The available research does not provide specific data on the effectiveness of SinuSonic for Nasal Congestion. Instead, it discusses other treatments like Narivent, nasal saline irrigation, and isotonic saline nasal irrigation, which have shown benefits for nasal congestion and related conditions. Without direct data on SinuSonic, it's unclear how it compares to these alternatives.12345
What safety data exists for SinuSonic for nasal congestion?
The provided research does not contain specific safety data for SinuSonic or SinuSonic Nasal Congestion Relief Device. The studies focus on other treatments like betamethasone nasal irrigation, Narivent®, and saline nasal irrigation, with saline nasal irrigation noted as safe with no serious adverse events reported. However, none of these studies directly address the safety of SinuSonic.26789
Is SinuSonic a promising treatment for nasal congestion?
What is the purpose of this trial?
The goal of this clinical trial is to evaluate the effects of using the SinuSonic on psychological and physical well-being in adults who have nasal/sinus congestion.The study aims are:* Aim #1: to evaluate the effect of the SinuSonic on physical and psychological well-being in individuals with chronic nasal congestion;* Aim #2: to evaluate the relationship between autonomic reactivity and psychological well-being (i.e., anxiety and depression) in individuals with chronic nasal congestion;* Exploratory Aim: to evaluate the impact of adverse experiences on physical and psychological well-being in individuals who experience chronic nasal congestion.Participants will be asked to complete self-report measures of physical health, mental health and autonomic regulation before using SinuSonic (i.e., baseline research session) and after 5 weeks of directed use (post-intervention). Demographic information and adverse experiences will be documented during the baseline research session. Participants will be asked to document (weekly) current nasal symptoms and SinuSonic usage.
Research Team
Keri J Heilman, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Eligibility Criteria
This trial is for adults with chronic nasal congestion who want to test a device called SinuSonic. It's designed to see if it can improve their physical and mental well-being. People with ongoing sinus issues, inflammation, or psychological impacts from nasal congestion may qualify.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Research Session
Participants complete self-report measures of physical health, mental health, autonomic regulation, and adverse experiences
Treatment
Participants use SinuSonic twice daily for 5 weeks and complete weekly forms to document usage and symptoms
Post-intervention Research Session
Participants complete self-report measures of symptoms, autonomic reactivity, and anxiety/depression after 5 weeks of SinuSonic use
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- SinuSonic
SinuSonic is already approved in United States for the following indications:
- Nasal congestion
- Sinus congestion
- Allergies
- Rhinologic symptoms
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
Healthy Humming, LLC
Industry Sponsor